Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16201 - 16225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	SRY	6736	downregulated	Carmustine results in decreased expression of SRY mRNA	Yp11.2	A21555
Carmustine	Approved Investigational	ST6GAL1	6480	upregulated	Carmustine results in increased expression of ST6GAL1 mRNA	3q27.3	A21555
Carmustine	Approved Investigational	ST8SIA1	6489	upregulated	Carmustine results in increased expression of ST8SIA1 mRNA	12p12.1	A21555
Carmustine	Approved Investigational	STAM	8027	downregulated	Carmustine results in decreased expression of STAM mRNA	10p12.33	A21555
Carmustine	Approved Investigational	STS	412	upregulated	Carmustine results in increased expression of STS mRNA	Xp22.31	A21555
Carmustine	Approved Investigational	STX1B	112755	downregulated	Carmustine results in decreased expression of STX1B mRNA	16p11.2	A21555
Carmustine	Approved Investigational	STXBP2	6813	downregulated	Carmustine results in decreased expression of STXBP2 mRNA	19p13.2	A21555
Carmustine	Approved Investigational	TAC1	6863	downregulated	Carmustine results in decreased expression of TAC1 mRNA	7q21.3	A21555
Carmustine	Approved Investigational	TCF21	6943	downregulated	Carmustine results in decreased expression of TCF21 mRNA	6q23.2	A21555
Carmustine	Approved Investigational	TLE3	7090	downregulated	Carmustine results in decreased expression of TLE3 mRNA	15q22	A21555
Carmustine	Approved Investigational	TNFRSF11B	4982	downregulated	Carmustine results in decreased expression of TNFRSF11B mRNA	8q24.12	A21555
Carmustine	Approved Investigational	TRAF1	7185	downregulated	Carmustine results in decreased expression of TRAF1 mRNA	9q33.2	A21555
Carmustine	Approved Investigational	TREX1	11277	upregulated	Carmustine results in increased expression of TREX1 mRNA	3p21.31	A21557
Carmustine	Approved Investigational	TSPAN4	7106	downregulated	Carmustine results in decreased expression of TSPAN4 mRNA	11p15.5	A21555
Carmustine	Approved Investigational	TUBB	203068	upregulated	Carmustine results in increased expression of TUBB mRNA	6p21.33	A21555
Carmustine	Approved Investigational	TUBG1	7283	downregulated	Carmustine results in decreased expression of TUBG1 mRNA	17q21.31	A21555
Carmustine	Approved Investigational	UGT8	7368	upregulated	Carmustine results in increased expression of UGT8 mRNA	4q26	A21555
Carmustine	Approved Investigational	UPF1	5976	downregulated	Carmustine results in decreased expression of UPF1 mRNA	19p13.11	A21555
Carmustine	Approved Investigational	VGF	7425	downregulated	Carmustine results in decreased expression of VGF mRNA	7q22.1	A21555
Carmustine	Approved Investigational	WIPF1	7456	downregulated	Carmustine results in decreased expression of WIPF1 mRNA	2q31.1	A21555
Carmustine	Approved Investigational	YWHAH	7533	downregulated	Carmustine results in decreased expression of YWHAH mRNA	22q12.3	A21555
Carmustine	Approved Investigational	ZBTB17	7709	downregulated	Carmustine results in decreased expression of ZBTB17 mRNA	1p36.13	A21555
Carmustine	Approved Investigational	ZYX	7791	downregulated	Carmustine results in decreased expression of ZYX mRNA	7q34	A21555
Carvedilol	Approved Investigational	EDN1	1906	downregulated	carvedilol results in decreased expression of EDN1 mRNA	6p24.1	A21558
Carvedilol	Approved Investigational	GJA1	2697	upregulated	carvedilol results in increased expression of GJA1 mRNA	6q22.31	A12466

Displaying entries 16201 - 16225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability